ANTARES TO LAUNCH ANUTROL TRIAL

A A

Antares Pharma is getting ready to initiate a Phase-III clinical trial for Anutrol, an experimental treatment for overactive bladder.

Anturol is a clear and odorless gel formulation of oxybutynin that is designed to be absorbed through the skin following a once-a-day application to the abdomen. The formulation uses Antares' proprietary advanced transdermal delivery platform.